GSK2646264 (Compound 44) is a potent and selective spleen tyrosine kinase (SYK) inhibitor with a pIC 50 of 7.1. GSK2646264 also inhibits other kinases with pIC 50 values of 5.4, 5.4, 5.3, 5, 4.5, In Vitro GSK2646264 (0.01-10 μM; 1 h) significantly inhibits anti‐IgE (but not C5a)‐induced histamine release from skin mast cells in a concentration‐dependent manner. The IC 50 is 0.7 μM and the IC 90 is 6.8 μM. GSK2646264 cream (0.5, 1, and 3% [wt/wt]; 1 cm 2 ; 4 and 24 h) inhibits anti‐IgE‐induced histamine release from mast cells in ex vivo human skin. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:SYK 7.1 (pIC 50 ) LCK 5.4 (pIC 50 ) LRRK2 5.4 (pIC 50 ) GSK3β 5.3 (pIC 50 ) JAK2 5 (pIC 50 ) VEGFR2 4.5 (pIC 50 ) Aurora B
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
GSK2646264
CAS number：1398695-47-0 molecular formula：C24H26N2O2
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | - | ||
| CAS number | 1398695-47-0 | molecular formula | C24H26N2O2 |
| molecular weight | 374.48 g/mol | Exact mass | ≥98% |
| PSA | 43.400 Ų | logp | 4.2 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
